Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibitory synaptic factor 2A (INSYN2A) is a protein that participates in the machinery of inhibitory synapses, acting likely as a scaffold to help organize synaptic components. It is predicted to play a role in postsynaptic inhibitory signaling, likely at GABAergic synapses, helping to dampen neuronal activity and maintain proper synaptic inhibition in the central nervous system. Expression of INSYN2A is enriched in various brain regions, particularly those with significant inhibitory neurotransmission such as the hippocampus, cortex, and basal ganglia. Its specific molecular mechanisms and any roles outside of the nervous system remain subjects of ongoing research. There are no approved drugs or common clinical applications linked to this protein as of present data, and its relevance as a disease gene or biomarker is not established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibitory synaptic factor 2A (INSYN2A).